Learn / RYTM
NASDAQ: RYTM
Rhythm Pharmaceuticals (RYTM) stock, explained like you're 5
Rhythm Pharmaceuticals trades on the Nasdaq under the ticker RYTM. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6.3 billion dollars.
- Ticker
- RYTM
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 6.3 billion dollars
Is Rhythm Pharmaceuticals a small, medium or large cap company?
No. Rhythm Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Rhythm Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves RYTM stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Rhythm Pharmaceuticals (RYTM) Upgraded to Buy: Here's What You Should Know (Yahoo Finance)
- William Blair initiates Rhythm Pharmaceuticals stock with outperform rating By Investing.com (Investing.com Nigeria)
- JPMorgan reports 3.56 million shares in Rhythm Pharmaceuticals (RYTM), exceeding the 5% threshold. (Stock Titan)
- Rhythm Pharmaceuticals Launches IMCIVREE in Japan for Acquired Hypothalamic Obesity Following MHLW Approval (Quiver Quantitative)
- JPMorgan cuts target to USD 145.00 for Rhythm Pharmaceuticals stock (ad-hoc-news.de)
Follow RYTM in your daily brief
Each trading day at 5 PM ET we post what happened to Rhythm Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow RYTM
Questions about Rhythm Pharmaceuticals stock
What does Rhythm Pharmaceuticals do?
Rhythm Pharmaceuticals trades on the Nasdaq under the ticker RYTM. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6.3 billion dollars.
What is the ticker symbol for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals trades under the ticker RYTM on the Nasdaq.
What is Rhythm Pharmaceuticals's market cap?
Rhythm Pharmaceuticals is a mid cap stock with a market cap of about 6.3 billion dollars.
How does Rhythm Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves RYTM stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow RYTM stock every day?
Add RYTM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.